Lüscher-Firzlaff J - Search Results

1

The interaction of MYC with the trithorax protein ASH2L promotes gene transcription by regulating H3K27 modification.

Ullius A, Lüscher-Firzlaff J, Costa IG, Walsemann G, Forst AH, Gusmao EG, Kapelle K, Kleine H, Kremmer E, Vervoorts J, Lüscher B. Ullius A, et al. Among authors: luscher firzlaff j. Nucleic Acids Res. 2014 Jun;42(11):6901-20. doi: 10.1093/nar/gku312. Epub 2014 Apr 29. Nucleic Acids Res. 2014. PMID: 24782528 Free PMC article.

2

Casein kinase II phosphorylation site mutations in c-Myb affect DNA binding and transcriptional cooperativity with NF-M.

Oelgeschläger M, Krieg J, Lüscher-Firzlaff JM, Lüscher B. Oelgeschläger M, et al. Mol Cell Biol. 1995 Nov;15(11):5966-74. doi: 10.1128/MCB.15.11.5966. Mol Cell Biol. 1995. PMID: 7565749 Free PMC article.

3

Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II.

Bousset K, Oelgeschläger MH, Henriksson M, Schreek S, Burkhardt H, Litchfield DW, Lüscher-Firzlaff JM, Lüscher B. Bousset K, et al. Cell Mol Biol Res. 1994;40(5-6):501-11. Cell Mol Biol Res. 1994. PMID: 7735324

4

Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.

Bousset K, Henriksson M, Lüscher-Firzlaff JM, Litchfield DW, Lüscher B. Bousset K, et al. Oncogene. 1993 Dec;8(12):3211-20. Oncogene. 1993. PMID: 8247525

5

Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding protein.

Austen M, Lüscher B, Lüscher-Firzlaff JM. Austen M, et al. J Biol Chem. 1997 Jan 17;272(3):1709-17. doi: 10.1074/jbc.272.3.1709. J Biol Chem. 1997. PMID: 8999850 Free article.

6

Regulation of cell growth by the Myc-Max-Mad network: role of Mad proteins and YY1.

Austen M, Cerni C, Henriksson M, Hilfenhaus S, Lüscher-Firzlaff JM, Menkel A, Seelos C, Sommer A, Lüscher B. Austen M, et al. Curr Top Microbiol Immunol. 1997;224:123-30. doi: 10.1007/978-3-642-60801-8_12. Curr Top Microbiol Immunol. 1997. PMID: 9308235 Review. No abstract available.

7

YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc.

Austen M, Cerni C, Lüscher-Firzlaff JM, Lüscher B. Austen M, et al. Oncogene. 1998 Jul 30;17(4):511-20. doi: 10.1038/sj.onc.1201968. Oncogene. 1998. PMID: 9696045

8

Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation.

Lüscher-Firzlaff JM, Westendorf JM, Zwicker J, Burkhardt H, Henriksson M, Müller R, Pirollet F, Lüscher B. Lüscher-Firzlaff JM, et al. Oncogene. 1999 Oct 7;18(41):5620-30. doi: 10.1038/sj.onc.1202967. Oncogene. 1999. PMID: 10523841

9

Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP.

Vervoorts J, Lüscher-Firzlaff JM, Rottmann S, Lilischkis R, Walsemann G, Dohmann K, Austen M, Lüscher B. Vervoorts J, et al. EMBO Rep. 2003 May;4(5):484-90. doi: 10.1038/sj.embor.embor821. EMBO Rep. 2003. PMID: 12776737 Free PMC article.

10

PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation.

Yu M, Schreek S, Cerni C, Schamberger C, Lesniewicz K, Poreba E, Vervoorts J, Walsemann G, Grötzinger J, Kremmer E, Mehraein Y, Mertsching J, Kraft R, Austen M, Lüscher-Firzlaff J, Lüscher B. Yu M, et al. Oncogene. 2005 Mar 17;24(12):1982-93. doi: 10.1038/sj.onc.1208410. Oncogene. 2005. PMID: 15674325

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters